Insider · CIK 0001873507
Mark E. Dmytruk
officer
Files at DNA (Ginkgo Bioworks Holdings, Inc.). First filing Nov 6, 2024, latest May 22, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $55k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DNA: Ginkgo Bioworks Holdings, Inc.
DNAOct 9, 2026 · close 13.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $5,355 706 shares | -2% | +33% from low-55% from high | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $9,060 1,244 shares | -3% | +32% from low-55% from high | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $6,103 790 shares | -2% | - | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $9,948 740 shares | -2% | - | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $7,558 645 shares | -2% | - | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $7,146 741 shares | -2% | - | |
| 8Weak | Ginkgo Bioworks Holdings, Inc. | $10k 1,322 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +454 | - | - | 45,907 | May 22, 2025 |
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 46,360 | May 22, 2025 |
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 46,932 | May 22, 2025 |
| May 21, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -706 | $7.59 | $5,355 | 46,226 | May 22, 2025 |
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -454 | - | - | 3,614 | May 22, 2025 |
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 9,970 | May 22, 2025 |
| May 20, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 19,488 | May 22, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +454 | - | - | 44,603 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 45,056 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 45,628 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +1,061 | - | - | 46,689 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +8 | - | - | 46,697 | Apr 23, 2025 |
| Apr 21, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -1,244 | $7.28 | $9,060 | 45,453 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -454 | - | - | 4,068 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 10,423 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 20,060 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,061 | - | - | 3,184 | Apr 23, 2025 |
| Apr 17, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class B Common Stockderivative | -8 | - | - | 5,906 | Apr 23, 2025 |
| Mar 13, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | CConversion Class A Common Stock | +9,497 | $0.00 | $0 | 44,149 | Mar 17, 2025 |
| Mar 13, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | CConversion Class B Common Stockderivative | -9,497 | $0.00 | $0 | 5,914 | Mar 17, 2025 |
| Mar 6, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,245 | - | - | 4,245 | Mar 10, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +454 | - | - | 34,417 | Mar 6, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 34,870 | Mar 6, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 35,442 | Mar 6, 2025 |
| Mar 4, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -790 | $7.73 | $6,103 | 34,652 | Mar 6, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -454 | - | - | 4,522 | Mar 6, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 10,876 | Mar 6, 2025 |
| Mar 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 20,632 | Mar 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +454 | - | - | 33,670 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 34,123 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 34,695 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +8 | - | - | 34,703 | Feb 6, 2025 |
| Feb 4, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -740 | $13.44 | $9,948 | 33,963 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -454 | - | - | 4,976 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 11,329 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 21,204 | Feb 6, 2025 |
| Feb 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class B Common Stockderivative | -8 | - | - | 15,411 | Feb 6, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +450 | - | - | 32,836 | Jan 8, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 33,289 | Jan 8, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 33,861 | Jan 8, 2025 |
| Jan 6, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -645 | $11.72 | $7,558 | 33,216 | Jan 8, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -450 | - | - | 5,430 | Jan 8, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 11,782 | Jan 8, 2025 |
| Jan 3, 2025 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 21,776 | Jan 8, 2025 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +484 | - | - | 32,094 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 32,547 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 33,119 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +8 | - | - | 33,127 | Dec 5, 2024 |
| Dec 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -741 | $9.64 | $7,146 | 32,386 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -484 | - | - | 5,880 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 12,235 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 22,348 | Dec 5, 2024 |
| Dec 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class B Common Stockderivative | -8 | - | - | 15,419 | Dec 5, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +1,634 | - | - | 31,871 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +453 | - | - | 32,324 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +572 | - | - | 32,896 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +36 | - | - | 32,932 | Nov 6, 2024 |
| Nov 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -1,322 | $7.58 | $10k | 31,610 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,634 | - | - | 6,364 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -453 | - | - | 12,688 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -572 | - | - | 22,920 | Nov 6, 2024 |
| Nov 1, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class B Common Stockderivative | -36 | - | - | 15,427 | Nov 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.